Chita-gun, Japan

Tomomi Nonomura


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2001-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tomomi Nonomura: Innovator in Anti-Inflammatory Compounds

Introduction

Tomomi Nonomura is a distinguished inventor based in Chita-gun, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory and analgesic agents. With a total of 4 patents to her name, Nonomura continues to push the boundaries of medical innovation.

Latest Patents

One of her latest patents involves sulfonylbenzene compounds that serve as anti-inflammatory and analgesic agents. This invention provides a compound of a specific formula, which includes various substituents and configurations aimed at treating medical conditions where prostaglandins are implicated as pathogens. The pharmaceutical composition derived from this invention holds promise for effective treatment options in the medical field.

Career Highlights

Nonomura is currently employed at Pfizer Corporation, a leading global pharmaceutical company. Her work focuses on the development of innovative compounds that can address pressing health issues. Her expertise and dedication to research have positioned her as a key player in her field.

Collaborations

Throughout her career, Nonomura has collaborated with notable colleagues, including Kazuo Ando and Tomoki Kato. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Tomomi Nonomura's contributions to the field of pharmaceuticals, particularly in anti-inflammatory compounds, highlight her role as a significant inventor. Her ongoing work at Pfizer Corporation and her innovative patents continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…